Georgina V. Long

Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors

R. Kefford, G. Long, P. Fernández-Peñas, 2013, The British journal of dermatology.

Phase I/II study to assess safety, pharmacokinetics, and efficacy of the oral MEK 1/2 inhibitor GSK1120212 (GSK212) dosed in combination with the oral BRAF inhibitor GSK2118436 (GSK436).

K. Flaherty, G. Shapiro, R. Kurzrock, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.